Frank-d V. Bohmer
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
Journal: Journal of cancer research and clinical oncology
Published: March 07, 2022
The translation attenuating arginine-rich sequence in the extended signal peptide of the protein-tyrosine phosphatase PTPRJ/DEP1 is conserved in mammals.
Journal: PloS one
Published: October 02, 2020
Mislocalisation of Activated Receptor Tyrosine Kinases - Challenges for Cancer Therapy.
Journal: Trends in molecular medicine
Published: April 20, 2020
Wild-type FLT3 and FLT3 ITD exhibit similar ligand-induced internalization characteristics.
Journal: Journal of cellular and molecular medicine
Published: September 30, 2019
Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
Journal: Journal of the neurological sciences
Published: September 23, 2019
SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells.
Journal: Leukemia
Published: January 23, 2019
Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia.
Journal: Haematologica
Published: June 09, 2018
Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis.
Journal: Scientific reports
Published: May 09, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.
Journal: Oncotarget
Published: November 30, 2017
Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AML.
Journal: Oncotarget
Published: July 27, 2017
In Situ Proximity Ligation Assay (In Situ PLA) to Assess PTP-Protein Interactions.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 13, 2016
Last Updated: 09/26/2026